» Articles » PMID: 21536654

Characterization of Basigin Isoforms and the Inhibitory Function of Basigin-3 in Human Hepatocellular Carcinoma Proliferation and Invasion

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2011 May 4
PMID 21536654
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Basigin, which has four isoforms, plays an important role in invasion of hepatocellular carcinoma (HCC). Detailed transcriptional regulation and functions of the basigin isoforms have not been reported except in the case of the predominant isoform basigin-2, which act as inducer of matrix metalloproteinases (MMPs). Here we determined that basigin-2, basigin-3, and basigin-4 were the most abundant transcript variants in human cell lines. GeneRacer PCR and luciferase reporter assays showed that basigin-3 and basigin-4 were initiated from an alternative promoter. Basigin-3 and basigin-4 were widely expressed in various normal human tissues at the mRNA level and were upregulated in HCC tissues compared to in normal tissues. Western blotting and confocal imaging showed that glycosylated basigin-3 and basigin-4 were expressed and localized to the plasma membrane. However, in cultured cell lines, only native basigin-3, and not basigin-4, was detected at protein level. Overexpression of basigin-3 inhibited HCC cell proliferation, MMP induction, and cell invasion in vitro and in vivo. Bimolecular fluorescence complementation assays and nuclear magnetic resonance (NMR) analysis indicated that basigin-3 interacted with basigin-2 to form hetero-oligomers. In conclusion, we systematically investigated the alternative splicing of basigin and found that basigin-3 could inhibit HCC proliferation and invasion, probably through interaction with basigin-2 as an endogenous inhibitor via hetero-oligomerization.

Citing Articles

Revolutionizing cancer treatment: an in-depth exploration of CAR-T cell therapies.

Kandav G, Chandel A Med Oncol. 2024; 41(11):275.

PMID: 39400611 DOI: 10.1007/s12032-024-02491-6.


BSG Isoform 2 (ENST00000353555) Is a Prognostic Biomarker in Predicting Unfavorable Overall Survival of Patients With Liver Hepatocellular Carcinoma.

Xiong W, Deng Y Cureus. 2024; 16(6):e61844.

PMID: 38975467 PMC: 11227378. DOI: 10.7759/cureus.61844.


Exploring monocarboxylate transporter inhibition for cancer treatment.

Koltai T, Fliegel L Explor Target Antitumor Ther. 2024; 5(1):135-169.

PMID: 38464385 PMC: 10918235. DOI: 10.37349/etat.2024.00210.


Embigin deficiency leads to delayed embryonic lung development and high neonatal mortality in mice.

Talvi S, Jokinen J, Sipila K, Rappu P, Zhang F, Poutanen M iScience. 2024; 27(2):108914.

PMID: 38318368 PMC: 10839689. DOI: 10.1016/j.isci.2024.108914.


Crosstalk Between Matrix Metalloproteinases and Their Inducer EMMPRIN/CD147: a Promising Therapeutic Target for Intracerebral Hemorrhage.

Liu Y, Qi L, Li Z, Yong V, Xue M Transl Stroke Res. 2023; .

PMID: 38100014 DOI: 10.1007/s12975-023-01225-6.


References
1.
Wu S, Ann D, Kim K, Lee V . Fine tuning of rabbit equilibrative nucleoside transporter activity by an alternatively spliced variant. J Drug Target. 2005; 13(8-9):521-33. DOI: 10.1080/10611860500403099. View

2.
Pajares M, Ezponda T, Catena R, Calvo A, Pio R, Montuenga L . Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol. 2007; 8(4):349-57. DOI: 10.1016/S1470-2045(07)70104-3. View

3.
Belton Jr R, Chen L, Mesquita F, Nowak R . Basigin-2 is a cell surface receptor for soluble basigin ligand. J Biol Chem. 2008; 283(26):17805-14. PMC: 2440618. DOI: 10.1074/jbc.M801876200. View

4.
Rosenstiel P, Huse K, Till A, Hampe J, Hellmig S, Sina C . A short isoform of NOD2/CARD15, NOD2-S, is an endogenous inhibitor of NOD2/receptor-interacting protein kinase 2-induced signaling pathways. Proc Natl Acad Sci U S A. 2006; 103(9):3280-5. PMC: 1413865. DOI: 10.1073/pnas.0505423103. View

5.
Delaglio F, Grzesiek S, Vuister G, Zhu G, Pfeifer J, Bax A . NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995; 6(3):277-93. DOI: 10.1007/BF00197809. View